Fingerprint
Dive into the research topics of 'Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
Janine Dretzke, Pelham Barton, Billingsley Kaambwa, Martin Connock, Olalekan Uthman, Susan Bayliss, Catherine Meads
Research output: Contribution to journal › Article › peer-review
3
Citations
(Scopus)